Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 928

1.

Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.

Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV; Canadian Cardiovascular Outcomes Research Team..

Can J Cardiol. 2004 Jan;20(1):61-7.

PMID:
14968144
2.

Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.

Cox JL, Ramer SA, Lee DS, Humphries K, Pilote L, Svenson L, Tu JV; Canadian Cardiovascular Outcomes Research Team Investigators..

Can J Cardiol. 2005 Mar 15;21(4):337-43.

PMID:
15838560
3.

Acute treatment of myocardial infarction in Canada 1999-2002.

Jackevicius CA, Alter D, Cox J, Daly P, Goodman S, Filate W, Newman A, Tu JV; Canadian Cardiovascular Outcomes Research Team..

Can J Cardiol. 2005 Feb;21(2):145-52.

PMID:
15729413
4.

Regional variation in the management of acute myocardial infarction in the province of Quebec.

Rodrigues EJ, Simpson E, Richard H, Pilote L.

Can J Cardiol. 2002 Oct;18(10):1067-76.

PMID:
12420042
5.

The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.

Haddad H, Searles G, Gillis A.

Can J Cardiol. 2001 Feb;17(2):179-83.

PMID:
11223488
7.

Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.

Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L.

Am Heart J. 2003 Mar;145(3):438-44.

PMID:
12660666
8.

Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.

Austin PC, Tu JV, Ko DT, Alter DA.

CMAJ. 2008 Oct 21;179(9):901-8. doi: 10.1503/cmaj.080295.

9.

Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.

Beck CA, Lauzon C, Eisenberg MJ, Huynh T, Dion D, Roux R, Racine N, Carignan S, Diodati JG, Charbonneau F, Lévesque C, Pouliot J J, Pilote L L.

Can J Cardiol. 2001 Jan;17(1):33-40.

PMID:
11173312
10.

Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?

Hudson M, Richard H, Pilote L.

Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):773-85.

PMID:
17486661
11.

Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.

Filippi A, D'Ambrosio G, Giustini SE, Pecchioli S, Mazzaglia G, Cricelli C.

J Cardiovasc Med (Hagerstown). 2009 Sep;10(9):714-8. doi: 10.2459/JCM.0b013e32832c6110.

PMID:
19465867
12.

Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995-2004.

Rasmussen S, Abildstrom SZ, Rasmussen JN, Gislason GH, Schramm TK, Folke F, Køber L, Torp-Pedersen C, Madsen M.

Med Care. 2008 Jan;46(1):70-7.

PMID:
18162858
13.

Trends in the in-hospital treatment of acute myocardial infarction between 1984 and 1993 - The Halifax County MONICA Project.

Gregor RD, Bata IR, Brownell B, Wolf HK.

Can J Cardiol. 2000 May;16(5):596-603.

PMID:
10833539
14.

Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.

Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP; REACH Investigators..

Crit Pathw Cardiol. 2009 Sep;8(3):104-11. doi: 10.1097/HPC.0b013e3181b8395d.

PMID:
19726929
15.

Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.

Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.

Can J Cardiol. 2005 May 1;21(6):485-8.

PMID:
15917876
17.

Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacotherapy use in primary care.

Farahani P, Levine M, Gaebel K, LeLorier J, Perrault S, Gillis J, Soon J.

Clin Invest Med. 2007;30(2):E63-9.

PMID:
17716543
19.

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment.

Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology..

Eur Heart J. 2003 Mar;24(5):464-74.

PMID:
12633547
20.

Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period.

Martínez M, Agustí A, Arnau JM, Vidal X, Laporte JR.

Eur J Clin Pharmacol. 1998 May;54(3):203-8.

PMID:
9681660

Supplemental Content

Support Center